Cargando…

Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis

Background: Flibanserin, a 5-HT(1A) agonist and 5-HT(2A) antagonist, is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. This post hoc analysis evaluated the effect of flibanserin treatment on body weight in premenopausal and postm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kornstein, Susan G., Simon, James A., Apfel, Stuart C., Yuan, James, Barbour, Krista A., Kissling, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695746/ https://www.ncbi.nlm.nih.gov/pubmed/28817365 http://dx.doi.org/10.1089/jwh.2016.6230

Ejemplares similares

Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016)

Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin
por: Simon, James A., et al.
Publicado: (2022)

Flibanserin: A controversial drug for female hypoactive sexual desire disorder
por: Baid, Rashmi, et al.
Publicado: (2018)

New developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
por: Jayne, Christopher J, et al.
Publicado: (2017)

Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
por: Revicki, Dennis A., et al.
Publicado: (2020)

Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study
por: Naguib, Marianne J., et al.
Publicado: (2021)

Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort Pilot Study
por: Oakley, Susan H., et al.
Publicado: (2016)

Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018)

Bremelanotide for Treatment of Female Hypoactive Sexual Desire
por: Edinoff, Amber N., et al.
Publicado: (2022)

Hypoactive sexual desire disorder caused by antiepileptic drugs
por: Singh, M., et al.
Publicado: (2015)

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019)

Flibanserin for Low Sexual Desire in Women: A Molecule From Bench to Bed?
por: Basson, Rosemary, et al.
Publicado: (2015)

The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
por: Uloko, Maria, et al.
Publicado: (2022)

Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022)

Role of hormones in hypoactive sexual desire disorder and current treatment
por: AlAwlaqi, Ahmed, et al.
Publicado: (2017)

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
por: Kingsberg, Sheryl A., et al.
Publicado: (2019)

Route to Benzimidazol-2-ones via Decarbonylative Ring Contraction of Quinoxalinediones: Application to the Synthesis of Flibanserin, A Drug for Treating Hypoactive Sexual Desire Disorder in Women and Marine Natural Product Hunanamycin Analogue
por: Shingare, Rahul D., et al.
Publicado: (2017)

Psychometric Properties of the Sexual Interest and Desire Inventory-Female for Diagnosis of Hypoactive Sexual Desire Disorder: The Persian Version
por: Malary, Mina, et al.
Publicado: (2016)

Women and Men’s Perspectives on the Factors Related to Women’s Dyadic Sexual Desire, and on the Treatment of Hypoactive Sexual Desire Disorder
por: Friedmann, Enav, et al.
Publicado: (2021)

Management of hypoactive sexual desire disorder in women: current and emerging therapies
por: Nappi, Rossella E, et al.
Publicado: (2010)

BIOPSYCHOSOCIAL DETERMINANTS OF HYPOACTIVE SEXUAL DESIRE IN WOMEN: A NARRATIVE REVIEW
por: Malary, Mina, et al.
Publicado: (2015)

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects
por: Millheiser, Leah, et al.
Publicado: (2019)

Socio-demographic determinants of low sexual desire and hypoactive sexual desire disorder: a population-based study in Iran
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2020)

Next‐day residual effects of flibanserin on simulated driving performance in premenopausal women
por: Kay, Gary G., et al.
Publicado: (2017)

A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes
por: Rochester-Eyeguokan, Charmaine, et al.
Publicado: (2017)

Body Image and Hypoactive Sexual Desire Disorder Relationship in a Representative Sample of Iranian Women
por: Hamzehgardeshi, Zeinab, et al.
Publicado: (2020)

Melanocortin 4 receptor agonism enhances sexual brain processing in women with hypoactive sexual desire disorder
por: Thurston, Layla, et al.
Publicado: (2022)

The Effect of Education on Sexual Health of Women with Hypoactive Sexual Desire Disorder: A Randomized Controlled Trial
por: Kaviani, Maasumeh, et al.
Publicado: (2014)

PMON214 Kisspeptin Restores Sexual and Attraction Brain Processing in Women with Hypoactive Sexual Desire Disorder
por: Thurston, Layla, et al.
Publicado: (2022)

Characteristics of Chinese women in need of enhanced sexual health attention and at risk of hypoactive sexual desire disorder
por: Luo, Lan, et al.
Publicado: (2023)

Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial
por: Thurston, Layla, et al.
Publicado: (2022)

Female sexual dysfunction: a focus on flibanserin
por: Lodise, Nicole M
Publicado: (2017)

What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire Disorder
por: Pyke, Robert, et al.
Publicado: (2016)

OR17-5 Kisspeptin Increases Penile Tumescence and Sexual Brain Processing in Men with Hypoactive Sexual Desire Disorder
por: Abbara, Ali, et al.
Publicado: (2022)

Flibanserin Approval: Facts or Feelings?
por: Simon, James A., et al.
Publicado: (2016)

Prevalence of Hypoactive Sexual Desire Disorder Among Sexually Active Postmenopausal Women With Metabolic Syndrome at a Public Hospital Clinic in Brazil: A Cross-sectional Study
por: Dutra da Silva, Gustavo Maximiliano, et al.
Publicado: (2020)

Differences in the Gut Microbiome of Women With and Without Hypoactive Sexual Desire Disorder: Case Control Study
por: Li, Guanjian, et al.
Publicado: (2021)

Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women
por: Cieri-Hutcherson, Nicole E., et al.
Publicado: (2021)

Cognitive-behavioral group therapy for women with hypoactive sexual desire: A pilot randomized study
por: Lerner, Théo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_srtitb2ngcl0k5ef7kuiqtq9dt